Influenza virus neuraminidase inhibitors
Top Cited Papers
- 1 March 2000
- journal article
- review article
- Published by Elsevier in The Lancet
- Vol. 355 (9206) , 827-835
- https://doi.org/10.1016/s0140-6736(99)11433-8
Abstract
No abstract availableKeywords
This publication has 42 references indexed in Scilit:
- Short-Term Treatment with Zanamivir to Prevent Influenza: Results of a Placebo-Controlled StudyClinical Infectious Diseases, 2000
- Use of the Selective Oral Neuraminidase Inhibitor Oseltamivir to Prevent InfluenzaNew England Journal of Medicine, 1999
- Efficacy and Safety of the Neuraminidase Inhibitor Zanamivirin the Treatment of Influenza A and B Virus InfectionsThe Journal of Infectious Diseases, 1999
- Disarming Flu VirusesScientific American, 1999
- ZanamivirDrug Safety, 1999
- New Approaches to Influenza ChemotherapyDrugs, 1998
- Effects of the Neuraminidase Inhibitor Zanamivir on Otologic Manifestations of Experimental Human InfluenzaThe Journal of Infectious Diseases, 1997
- Influenza Neuraminidase Inhibitors Possessing a Novel Hydrophobic Interaction in the Enzyme Active Site: Design, Synthesis, and Structural Analysis of Carbocyclic Sialic Acid Analogues with Potent Anti-Influenza ActivityJournal of the American Chemical Society, 1997
- Rational design of potent sialidase-based inhibitors of influenza virus replicationNature, 1993
- Three-dimensional structure of the neuraminidase of influenza virus A/Tokyo/3/67 at 2·2 Å resolutionJournal of Molecular Biology, 1991